We positively detected serum AQP4-IgG in 23 (76.7%) patients, optic neuritis in 7 (23.3%) patients, myelitis in 16 (53.3%) patients, brain attacks in 3 (10%) patients, and mix attacks in 4 (13.3%) patients. Here, AQP4 is linked to myelitis.